Lombard Odier Asset Management (USA) Corp sold 3,334,000 shares of Bausch Health Companies, with a position value decline of approximately $22,564,800. This change represents about 1.53% of the company’s reportable U.S. equity assets. Post-trade holding stands at 1,716,000 shares valued at approximately $11,068,200, now outside the fund’s top holdings.

The reduction in Bausch Health Companies shares by Lombard Odier Asset Management (USA) Corp was revealed in a Securities and Exchange Commission (SEC) filing on November 14, 2025. The position’s value decreased to $11.07 million, with 1,716,000 shares remaining in the portfolio. This change means the company now accounts for 0.74% of the fund’s assets.

Bausch Health Companies Inc. is a global healthcare company with a diverse product portfolio. It generates revenue from pharmaceuticals, medical devices, and consumer health products. Lombard Odier’s decision to shrink its position in Bausch Health signals a reevaluation of the company’s potential amidst ongoing market challenges. The company’s stock price has declined by 24.6% over the past year.

Read more at Nasdaq: Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake